1013344

Novo Nordisk Inc. — FEI 2244771

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
April 13, 2017
Fiscal Year
2017
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Plainsboro, NJ (United States)

Additional Details

Sponsor, Contract Research Organization

Citations

IDCFRDescription
748221 CFR 312.50General responsibilities of sponsors